Personal information

Activities

Collapse all

Employment (1)

Mayo Clinic: Rochester, Minnesota, US

(Department of Laboratory Medicine and Pathology)
Employment
Source: Self-asserted source
Mazen Atiq

Works (4)

Determination of the Duplicated CYP2D6 Allele Using Real-Time PCR Signal: An Alternative Approach

Journal of Personalized Medicine
2023-05-24 | Journal article
DOI: 10.3390/jpm13060883
Part of ISSN: 2075-4426
Contributors: Mazen A. Atiq; Sandra E. Peterson; Loralie J. Langman; Linnea M. Baudhuin; John L. Black; Ann M. Moyer
Source: Self-asserted source
Mazen Atiq

RNA-Seq Reveals Differences in Expressed Tumor Mutation Burden in Colorectal and Endometrial Cancers with and without Defective DNA-Mismatch Repair.

The Journal of molecular diagnostics : JMD
2021-02-04 | Journal article
DOI: 10.1016/j.jmoldx.2021.01.008
PMID: 33549857
Contributors: DiGuardo MA; Davila JI; Jackson RA; Nair AA; Fadra N; Minn KT; Atiq MA; Zarei S; Blommel JH; Knight SM et al.
Source: Self-asserted source
Mazen Atiq

Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST).

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2020-07-15 | Journal article
DOI: 10.1038/s41379-020-0623-z
PMID: 32669612
Contributors: Atiq MA; Davis JL; Jason Hornick; Brendan Dickson; Fletcher CDM; Fletcher JA; Folpe AL; Adrian Marino-Enriquez
Source: Self-asserted source
Mazen Atiq

RNA sequencing identifies a novel USP9X-USP6 promoter swap gene fusion in a primary aneurysmal bone cyst.

Genes, chromosomes & cancer
2019-03-06 | Journal article
DOI: 10.1002/gcc.22742
PMID: 30767316
Contributors: Patrick R. Blackburn; Davila JI; Jackson RA; Fadra N; Atiq MA; Beth Pitel; Nair AA; VanDeWalker TJ; Hessler MG; Hovel SK et al.
Source: Self-asserted source
Mazen Atiq

Peer review (2 reviews for 1 publication/grant)

Review activity for Neuroscience and biobehavioral reviews. (2)
How many people are using ORCID?